Ilana Goldberg alias Dr. Root Cause Rupa

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure autoimmune disease.

autoimmune disease

Supports

High-quality reviews define autoimmune diseases as conditions where the immune system inappropriately targets the body’s own cells and tissues, often via autoreactive T and B cells and pathogenic autoantibodies, leading to chronic inflammation and organ dysfunction.^{[1][2][3][4][5][6][14][20][21]} Large epidemiologic analyses and reviews indicate that there are more than 80–100 distinct autoimmune diseases, with common examples including type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, psoriasis, celiac disease, autoimmune thyroid disease, inflammatory bowel disease, Sjögren’s syndrome, and autoimmune hepatitis.^{[1][3][6][14][18][21]} Background reviews and national health agencies report that autoimmune diseases collectively affect roughly 3–10% of the population, with recent data suggesting rising incidence and prevalence over recent decades.^{[15][17][18][21][24]} Systematic and guideline-level work shows that autoimmune diseases typically result from interactions between genetic susceptibility (e.g., HLA variants, other risk alleles) and environmental exposures (infections, chemicals, diet, drugs, smoking, UV, microbiome) that lead to breakdown of immune tolerance.^{[1][2][3][7][14][15][18][21][24]} Major rheumatology and hepatology guidelines (e.g., for rheumatoid arthritis, spondyloarthropathies, autoimmune hepatitis) emphasize immunomodulatory or immunosuppressive therapy as standard of care, including corticosteroids, conventional disease-modifying antirheumatic drugs, and targeted biologic agents such as TNF inhibitors, with substantial evidence from randomized trials and meta-analyses that these reduce disease activity and prevent damage.^{[4][5][13][19][22][25]}

Contradicts

The indexed clinical trials provided (perioperative chemotherapy plus toripalimab for EBV-associated gastric cancer, home caffeine for apnea of prematurity, axitinib with radiotherapy for hepatocellular carcinoma, and antimicrobial photodynamic therapy for dental biofilm) are not autoimmune-focused and therefore do not provide direct evidence about autoimmune disease pathogenesis, prevalence, or standard treatment, limiting their relevance to the claim. Although debates exist around specific environmental triggers or proposed novel therapeutics (such as helminth or schistosome-derived antigens), current evidence is largely preclinical or early-phase and does not yet support broad claims that such approaches are established treatments or “cures” for autoimmune diseases.^[7][8] High-quality reviews and guidelines repeatedly state that most autoimmune diseases have no definitive cure and require long-term management, which contradicts any influencer claim that autoimmune diseases are generally curable with simple or single interventions.^{[11][14][15][17][21][22][23]} Evidence on the exact reasons for the rising prevalence is still incomplete and multifactorial, so strong causal claims attributing the increase to one predominant factor (e.g., one chemical, one food type, or a single vaccine) are not supported by systematic epidemiologic reviews.^{[7][14][15][18][21][24]}

Mainstream view

Mainstream medical and scientific consensus is that autoimmune diseases are a large, heterogeneous group of chronic disorders in which the immune system mistakenly targets self-antigens, driven by complex interactions of genetic predisposition and environmental factors, and manifesting as organ-specific or systemic inflammation and damage.^{[1][2][3][4][5][6][14][20][21]} There are more than 80 recognised autoimmune diseases, collectively affecting several percent of the population, with incidence and prevalence increasing over recent decades.^{[14][15][17][18][21][24]} For most autoimmune diseases, there is no cure; instead, standard care focuses on early diagnosis, risk stratification, and long-term management using immunomodulatory or immunosuppressive therapies (including biologics and small molecules) to control disease activity, prevent tissue damage, and improve quality of life.^{[4][5][11][13][19][21][22][23][25]} Current guidelines and high-quality reviews emphasise individualized treatment plans, monitoring for adverse effects, and, increasingly, targeted therapies informed by molecular, omics, and epigenetic insights, but they do not support simplistic or universal “reverse autoimmune disease” strategies.^{[1][3][5][9][10][16][22]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“autoimmune disease”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure hormone imbalance.

hormone imbalance

Supports

High-quality evidence supports the general medical concept that clinically significant hormone imbalances (endocrine disorders) exist, are diagnosable, and can cause systemic symptoms and disease. Large narrative and epidemiologic reviews describe endocrine diseases (thyroid disorders, diabetes, PCOS, adrenal disorders, hypogonadism, etc.) as common and important contributors to morbidity and mortality, emphasizing that disruption of normal hormone levels leads to recognizable clinical syndromes and long-term complications.^[12] Major endocrine society and related guidelines (Endocrine Society, AACE, European endocrine guidelines) provide detailed, evidence-based diagnostic and treatment algorithms for specific hormone excess or deficiency states (e.g., hypothyroidism, hyperthyroidism, PCOS, diabetes, adrenal insufficiency), implicitly endorsing “hormonal imbalance” as a valid pathophysiologic concept when defined biochemically and clinically.^{[13][16][19][25]} Reviews on hormonal imbalance and cancer, such as in breast cancer, highlight that abnormal estrogen/progesterone signaling and other hormonal disruptions are established risk and progression factors, reinforcing that hormone imbalance is a recognized mechanism in serious disease.^[8][9] Comprehensive reviews of reproductive health show that altered levels of sex steroids, gonadotropins, thyroid hormones, and prolactin are clearly linked with menstrual disturbances, infertility, and other gynecologic and andrologic conditions, again supporting the concept that measured deviation from normal hormone ranges is clinically meaningful.^[6][15]

Contradicts

The available high-quality literature does not support “hormone imbalance” as a single, vague diagnosis responsible for nonspecific symptoms without objective endocrine abnormalities; instead, it consistently treats hormone-related disorders as specific, measurable conditions (e.g., hypothyroidism, PCOS, Cushing’s syndrome, hypogonadism) with defined diagnostic criteria.^{[5][6][21][24]} Major guidelines emphasize targeted testing and careful differential diagnosis rather than broad, non-specific attribution of fatigue, weight changes, or mood symptoms to hormone imbalance alone, noting that many such complaints have multifactorial or non-endocrine causes.^{[13][16][21][24]} Reviews of psychiatric and menstrual disorders show that while hormones influence mood and cycles, clear-cut “hormone-specific” psychiatric diagnoses are rare and the relationship is complex, cautioning against simplistic claims that most mental health or menstrual problems are due to generic hormone imbalance.^[3][6][10] The index trials provided (interferon gamma pneumonia prevention, toddler taste study, post-denosumab osteoporosis management, and a Harry Potter mental wellness intervention) do not address hormone imbalance mechanisms or treatment and therefore do not substantiate broad influencer-type claims about hormone imbalance.

Mainstream view

Mainstream medicine accepts hormone imbalance as a valid concept only when tied to specific, objectively demonstrable endocrine disorders (such as thyroid disease, diabetes, PCOS, adrenal insufficiency, hypogonadism) with established diagnostic criteria, laboratory thresholds, and evidence-based treatments. Clinicians and guidelines view the endocrine system as a network of more than 50 hormones whose excess or deficiency can significantly impact metabolism, growth, reproduction, mood, and other systems, but they stress that diagnosis requires targeted history, examination, and appropriate laboratory and imaging tests rather than reliance on symptoms alone.^{[13][14][17][21][24]} The mainstream position is that many serious chronic conditions (diabetes, thyroid disease, reproductive disorders, some cancers, osteoporosis) involve well-characterized hormonal imbalances and should be managed using guideline-directed therapies, while broad non-specific claims that “hormone imbalance” is the root cause of most common symptoms or can be reliably diagnosed or treated through non-standard or unvalidated methods are not supported by high-quality evidence.^{[5][6][13][16][21][24]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“hormone imbalance”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure addressing hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health.

addressing hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health

Supports

High-quality evidence supports the general medical concept that clinically significant hormone imbalances (endocrine disorders) exist, are diagnosable, and can cause systemic symptoms and disease. Large narrative and epidemiologic reviews describe endocrine diseases (thyroid disorders, diabetes, PCOS, adrenal disorders, hypogonadism, etc.) as common and important contributors to morbidity and mortality, emphasizing that disruption of normal hormone levels leads to recognizable clinical syndromes and long-term complications.^[12] Major endocrine society and related guidelines (Endocrine Society, AACE, European endocrine guidelines) provide detailed, evidence-based diagnostic and treatment algorithms for specific hormone excess or deficiency states (e.g., hypothyroidism, hyperthyroidism, PCOS, diabetes, adrenal insufficiency), implicitly endorsing “hormonal imbalance” as a valid pathophysiologic concept when defined biochemically and clinically.^{[13][16][19][25]} Reviews on hormonal imbalance and cancer, such as in breast cancer, highlight that abnormal estrogen/progesterone signaling and other hormonal disruptions are established risk and progression factors, reinforcing that hormone imbalance is a recognized mechanism in serious disease.^[8][9] Comprehensive reviews of reproductive health show that altered levels of sex steroids, gonadotropins, thyroid hormones, and prolactin are clearly linked with menstrual disturbances, infertility, and other gynecologic and andrologic conditions, again supporting the concept that measured deviation from normal hormone ranges is clinically meaningful.^[6][15]

Contradicts

The available high-quality literature does not support “hormone imbalance” as a single, vague diagnosis responsible for nonspecific symptoms without objective endocrine abnormalities; instead, it consistently treats hormone-related disorders as specific, measurable conditions (e.g., hypothyroidism, PCOS, Cushing’s syndrome, hypogonadism) with defined diagnostic criteria.^{[5][6][21][24]} Major guidelines emphasize targeted testing and careful differential diagnosis rather than broad, non-specific attribution of fatigue, weight changes, or mood symptoms to hormone imbalance alone, noting that many such complaints have multifactorial or non-endocrine causes.^{[13][16][21][24]} Reviews of psychiatric and menstrual disorders show that while hormones influence mood and cycles, clear-cut “hormone-specific” psychiatric diagnoses are rare and the relationship is complex, cautioning against simplistic claims that most mental health or menstrual problems are due to generic hormone imbalance.^[3][6][10] The index trials provided (interferon gamma pneumonia prevention, toddler taste study, post-denosumab osteoporosis management, and a Harry Potter mental wellness intervention) do not address hormone imbalance mechanisms or treatment and therefore do not substantiate broad influencer-type claims about hormone imbalance.

Mainstream view

Mainstream medicine accepts hormone imbalance as a valid concept only when tied to specific, objectively demonstrable endocrine disorders (such as thyroid disease, diabetes, PCOS, adrenal insufficiency, hypogonadism) with established diagnostic criteria, laboratory thresholds, and evidence-based treatments. Clinicians and guidelines view the endocrine system as a network of more than 50 hormones whose excess or deficiency can significantly impact metabolism, growth, reproduction, mood, and other systems, but they stress that diagnosis requires targeted history, examination, and appropriate laboratory and imaging tests rather than reliance on symptoms alone.^{[13][14][17][21][24]} The mainstream position is that many serious chronic conditions (diabetes, thyroid disease, reproductive disorders, some cancers, osteoporosis) involve well-characterized hormonal imbalances and should be managed using guideline-directed therapies, while broad non-specific claims that “hormone imbalance” is the root cause of most common symptoms or can be reliably diagnosed or treated through non-standard or unvalidated methods are not supported by high-quality evidence.^{[5][6][13][16][21][24]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“addressing hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure A Holistic Approach To HASHIMOTO’S AUTOIMMUNE THYROIDITIS.

A Holistic Approach To HASHIMOTO’S AUTOIMMUNE THYROIDITIS

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“A Holistic Approach To HASHIMOTO’S AUTOIMMUNE THYROIDITIS”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise Diagnosing and treating systemic autoimmune diseases, which are outside chiropractic scope. as within their scope of practice.

Diagnosing and treating systemic autoimmune diseases, which are outside chiropractic scope.

Supports

High-quality reviews define autoimmune diseases as conditions where the immune system inappropriately targets the body’s own cells and tissues, often via autoreactive T and B cells and pathogenic autoantibodies, leading to chronic inflammation and organ dysfunction.^{[1][2][3][4][5][6][14][20][21]} Large epidemiologic analyses and reviews indicate that there are more than 80–100 distinct autoimmune diseases, with common examples including type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, psoriasis, celiac disease, autoimmune thyroid disease, inflammatory bowel disease, Sjögren’s syndrome, and autoimmune hepatitis.^{[1][3][6][14][18][21]} Background reviews and national health agencies report that autoimmune diseases collectively affect roughly 3–10% of the population, with recent data suggesting rising incidence and prevalence over recent decades.^{[15][17][18][21][24]} Systematic and guideline-level work shows that autoimmune diseases typically result from interactions between genetic susceptibility (e.g., HLA variants, other risk alleles) and environmental exposures (infections, chemicals, diet, drugs, smoking, UV, microbiome) that lead to breakdown of immune tolerance.^{[1][2][3][7][14][15][18][21][24]} Major rheumatology and hepatology guidelines (e.g., for rheumatoid arthritis, spondyloarthropathies, autoimmune hepatitis) emphasize immunomodulatory or immunosuppressive therapy as standard of care, including corticosteroids, conventional disease-modifying antirheumatic drugs, and targeted biologic agents such as TNF inhibitors, with substantial evidence from randomized trials and meta-analyses that these reduce disease activity and prevent damage.^{[4][5][13][19][22][25]}

Contradicts

The indexed clinical trials provided (perioperative chemotherapy plus toripalimab for EBV-associated gastric cancer, home caffeine for apnea of prematurity, axitinib with radiotherapy for hepatocellular carcinoma, and antimicrobial photodynamic therapy for dental biofilm) are not autoimmune-focused and therefore do not provide direct evidence about autoimmune disease pathogenesis, prevalence, or standard treatment, limiting their relevance to the claim. Although debates exist around specific environmental triggers or proposed novel therapeutics (such as helminth or schistosome-derived antigens), current evidence is largely preclinical or early-phase and does not yet support broad claims that such approaches are established treatments or “cures” for autoimmune diseases.^[7][8] High-quality reviews and guidelines repeatedly state that most autoimmune diseases have no definitive cure and require long-term management, which contradicts any influencer claim that autoimmune diseases are generally curable with simple or single interventions.^{[11][14][15][17][21][22][23]} Evidence on the exact reasons for the rising prevalence is still incomplete and multifactorial, so strong causal claims attributing the increase to one predominant factor (e.g., one chemical, one food type, or a single vaccine) are not supported by systematic epidemiologic reviews.^{[7][14][15][18][21][24]}

Mainstream view

Mainstream medical and scientific consensus is that autoimmune diseases are a large, heterogeneous group of chronic disorders in which the immune system mistakenly targets self-antigens, driven by complex interactions of genetic predisposition and environmental factors, and manifesting as organ-specific or systemic inflammation and damage.^{[1][2][3][4][5][6][14][20][21]} There are more than 80 recognised autoimmune diseases, collectively affecting several percent of the population, with incidence and prevalence increasing over recent decades.^{[14][15][17][18][21][24]} For most autoimmune diseases, there is no cure; instead, standard care focuses on early diagnosis, risk stratification, and long-term management using immunomodulatory or immunosuppressive therapies (including biologics and small molecules) to control disease activity, prevent tissue damage, and improve quality of life.^{[4][5][11][13][19][21][22][23][25]} Current guidelines and high-quality reviews emphasise individualized treatment plans, monitoring for adverse effects, and, increasingly, targeted therapies informed by molecular, omics, and epigenetic insights, but they do not support simplistic or universal “reverse autoimmune disease” strategies.^{[1][3][5][9][10][16][22]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“autoimmune disease”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise Functional Medicine for Autoimmune Disease as within their scope of practice.

Functional Medicine for Autoimmune Disease

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“autoimmune disease”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure digestive disorders.

digestive disorders

Supports

Several randomized controlled trials and reviews indicate that turmeric or its active constituent curcumin may have therapeutic effects in certain digestive disorders, particularly functional dyspepsia and some forms of inflammatory bowel disease. ^[17][19] A systematic review and meta-analysis protocol specifically aims to evaluate turmeric for dyspepsia, peptic ulcer disease, inflammatory bowel disease, irritable bowel syndrome, Crohn’s disease, ulcerative colitis, and gastroesophageal reflux disease, reflecting sufficient preliminary evidence to justify formal evidence synthesis. ^[18][20] An RCT in patients with dyspeptic complaints reported that 87% of turmeric-treated patients experienced symptom relief after 7 days versus 53% in the placebo group, suggesting short-term benefit for dyspepsia. A randomized double‑blind trial comparing curcumin with omeprazole for functional dyspepsia found comparable improvements in symptom scores in all treatment arms, indicating that curcumin can relieve functional dyspepsia to a similar extent as a standard proton‑pump inhibitor under trial conditions. Review articles and narrative syntheses of clinical trials conclude that turmeric and curcumin may help treat digestive disorders, particularly irritable bowel syndrome, and report improvements in IBS symptom severity and quality of life in several studies, although many used multi‑herb combinations or had methodological limitations. A broader review of turmeric for digestive disorders reports RCT evidence of benefit for dyspepsia and suggests curcumin can reduce relapse rates in ulcerative colitis when added to standard therapy, indicating potential adjunctive efficacy in this IBD subtype. contradicts

In their own wordsView sourceArchived copy

“digestive disorders”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure chronic inflammation.

chronic inflammation

Supports

High-quality evidence strongly links chronic, usually low-grade, inflammation with the development and progression of many chronic diseases, especially cardiometabolic disease and functional decline in aging populations.^[11] Epidemiologic and cohort data show that systemic inflammatory markers (e.g., CRP, composite inflammation scores) are associated with higher risk of cardiometabolic multimorbidity, earlier onset of cardiometabolic disease, and late-life functional limitations.^[8][10] Editorial and narrative reviews from major journals describe chronic inflammation as a shared pathway in autoimmune, infectious, and degenerative diseases, and as a key contributor to cardiovascular disease, cancer, diabetes, and neurodegenerative conditions.^{[1][4][9][17]} Large guideline frameworks for cardiovascular prevention and management recognize persistently elevated inflammatory markers (e.g., hsCRP) as a risk-enhancing factor and residual inflammatory risk in atherosclerotic disease, implying a causal or at least strongly contributory role for chronic inflammation in adverse cardiovascular outcomes.^[0][12] Comprehensive clinical resources and position pieces (e.g., StatPearls, major academic and clinical organizations) consistently state that chronic inflammation is associated with increased morbidity and mortality across cardiovascular, metabolic, autoimmune, malignant, neurodegenerative, and mental health conditions.^[11][16]

Contradicts

Despite strong associations, high-quality evidence does not support the simplistic assertion that chronic inflammation is the single cause of all diseases or that it fully explains every chronic condition.^[4][25] Causality is complex, bidirectional, and often disease-specific; for many conditions, inflammation is one component among genetic, environmental, infectious, and lifestyle factors, not an exclusive cause.^[4][6][11] Some cardiovascular cohorts show that low-grade inflammation (hsCRP) is an independent predictor of vascular and all-cause mortality but not necessarily of specific cardiovascular events in certain high-risk subgroups, indicating that the relationship can vary by population and outcome.^[15] Existing guidelines for hypertension and clinical nutrition in inflammatory diseases manage inflammation as one of several risk domains and do not endorse inflammation-focused interventions as sole or universally effective treatments.^[0][1][2] Editorials and reviews highlight that while the concept of chronic inflammation is widely accepted, there remain gaps in mechanistic understanding and a lack of unified anti-inflammatory guidelines for broad chronic disease prevention, underscoring that the field is still evolving and that some popular claims overstate the certainty and universality of the evidence.^[4]

Mainstream view

Mainstream medicine defines chronic inflammation as a persistent, dysregulated inflammatory state that can last months to years and is a major contributing factor to many common chronic diseases, especially cardiometabolic, autoimmune, malignant, and neurodegenerative conditions.^[11][16] It is viewed as a key pathway that interacts with genetic susceptibility, lifestyle, infections, and social determinants, rather than as a standalone explanation for all illness.^[4][6][11] Large cardiovascular and prevention guidelines treat chronic low-grade inflammation, often measured by hsCRP or similar biomarkers, as an important risk-enhancing factor and a potential therapeutic target, but still within a broader framework that prioritizes established risk factors (blood pressure, lipids, glycemic control, smoking, etc.).^[0][12] Overall, the consensus is that reducing modifiable drivers of chronic inflammation (e.g., obesity, sedentary behavior, poor diet, smoking, certain infections) is beneficial for long-term health, yet claims that chronic inflammation is the sole or universal cause of disease are considered oversimplified and not fully supported by current evidence.^[4][11][25]

In their own wordsView sourceArchived copy

“chronic inflammation”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise metabolic health as within their scope of practice.

metabolic health

Supports

High-quality evidence shows that specific pharmacologic and dietary interventions can improve certain aspects of metabolic health in people with type 2 diabetes or obesity. A systematic review and meta-analysis of randomized clinical trials found that dopamine agonists (bromocriptine and cabergoline) reduce HbA1c, fasting plasma glucose, and triglycerides compared with placebo in adults with type 2 diabetes, without an increase in serious adverse events, although the overall GRADE quality was low to moderate. ^[30][31][33] Additional systematic and narrative reviews of dopamine D2 agonists in type 2 diabetes describe beneficial effects on glucose homeostasis and some cardiometabolic parameters, supporting their role as one option in metabolic management. ^[32] A systematic review with meta-analysis and trial sequential analysis of clinical trials on licorice consumption showed statistically significant reductions in body weight and BMI, indicating a modest favorable effect on obesity indices and some aspects of metabolic profile. Follow-up analyses confirm that licorice-containing products, especially licorice flavonoid oil, can modestly reduce body fat mass and improve some metabolic markers in certain populations, although effect sizes are small and heterogeneous. Major cardiovascular and cardiometabolic guidelines and presidential advisories (e. g. , on cardiovascular–kidney–metabolic health and cardiometabolic risk clustering) reinforce that metabolic health is a modifiable construct encompassing glycemia, blood pressure, lipids, adiposity, and kidney function, and that these can be improved via lifestyle, pharmacotherapy, and risk-factor control in line with standard diabetes and cardiovascular prevention strategies.

Contradicts

The evidence supporting dopamine agonists and licorice as broad, primary tools for "metabolic health" is limited and does not justify strong, generalized influencer claims. ^[31][32] The dopamine agonist meta-analysis reports substantial heterogeneity (I² = 80%) and rates the certainty of evidence as low to moderate, meaning confidence in the magnitude and consistency of benefit is limited; only one large trial reported serious adverse events, so long-term safety and cardiovascular outcomes remain unclear. Dopamine agonists are not first-line glucose-lowering agents in major diabetes guidelines and are typically considered adjunct or niche therapies, which contradicts any claim that they are central or superior solutions for metabolic health. ^[30][33] The licorice meta-analysis, while showing weight and BMI reduction, also finds a statistically significant increase in diastolic blood pressure associated with hypernatremia, highlighting potentially harmful cardiovascular effects and undermining any simple "metabolic health" narrative based on licorice consumption. Reviews of licorice products stress that protective metabolic effects are inconsistent in people with established metabolic disturbances such as obesity or diabetes, and that chronic use can be associated with hypertension and electrolyte abnormalities, indicating that the net cardiometabolic impact may be neutral or even negative in some individuals. Overall, there is no high-quality evidence that these interventions alone produce comprehensive, long-term metabolic health across diverse populations, and the existing RCTs and meta-analyses do not support broad, influencer-style claims if those imply large, risk-free, generalizable benefits.

Mainstream view

Mainstream medical and scientific consensus defines metabolic health in terms of a cluster of cardiometabolic risk factors: normal glycemia, optimal blood pressure, favorable lipid profile, healthy body weight and waist circumference, absence of diabetes and cardiovascular disease, and preserved kidney function. ^[32] Major cardiometabolic and cardiovascular–kidney–metabolic frameworks emphasize that improving metabolic health requires multifactorial management: diet quality, physical activity, weight control, blood pressure and lipid management, smoking cessation, and guideline-directed pharmacotherapy for diabetes and cardiovascular risk. Within this framework, dopamine agonists such as bromocriptine are recognized as approved but relatively specialized glucose-lowering agents that can modestly improve glycemic and some lipid parameters in type 2 diabetes, but they are not cornerstone therapies and are used selectively when indicated. ^[30][31][33] Licorice or licorice flavonoid products are not recommended in major guidelines as routine metabolic health interventions because benefits on weight or metabolic indices are small, population-specific, and counterbalanced by consistent concerns about blood pressure elevation and electrolyte disturbances. Therefore, the mainstream position is that metabolic health is best addressed through comprehensive lifestyle and risk-factor management plus established first-line medications (e. g. , metformin, GLP-1 receptor agonists, SGLT2 inhibitors, statins, antihypertensives), with dopamine agonists and licorice-derived products playing at most a minor, adjunctive, and carefully monitored

In their own wordsView sourceArchived copy

“metabolic health”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise identifying and addressing the root causes of chronic symptoms instead of simply suppressing them as within their scope of practice.

identifying and addressing the root causes of chronic symptoms instead of simply suppressing them

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“identifying and addressing the root causes of chronic symptoms instead of simply suppressing them”

Rule: Virginia Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise using the most advanced diagnostic testing to identify the root causes, a completely personalized treatment protocol is designed as within their scope of practice.

using the most advanced diagnostic testing to identify the root causes, a completely personalized treatment protocol is designed

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“using the most advanced diagnostic testing to identify the root causes, a completely personalized treatment protocol is designed”

Rule: Virginia Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Diagnosing and treating hormone imbalances and metabolic health issues, which are outside chiropractic scope..

Diagnosing and treating hormone imbalances and metabolic health issues, which are outside chiropractic scope.

Supports

High-quality evidence supports the general medical concept that clinically significant hormone imbalances (endocrine disorders) exist, are diagnosable, and can cause systemic symptoms and disease. Large narrative and epidemiologic reviews describe endocrine diseases (thyroid disorders, diabetes, PCOS, adrenal disorders, hypogonadism, etc.) as common and important contributors to morbidity and mortality, emphasizing that disruption of normal hormone levels leads to recognizable clinical syndromes and long-term complications.^[12] Major endocrine society and related guidelines (Endocrine Society, AACE, European endocrine guidelines) provide detailed, evidence-based diagnostic and treatment algorithms for specific hormone excess or deficiency states (e.g., hypothyroidism, hyperthyroidism, PCOS, diabetes, adrenal insufficiency), implicitly endorsing “hormonal imbalance” as a valid pathophysiologic concept when defined biochemically and clinically.^{[13][16][19][25]} Reviews on hormonal imbalance and cancer, such as in breast cancer, highlight that abnormal estrogen/progesterone signaling and other hormonal disruptions are established risk and progression factors, reinforcing that hormone imbalance is a recognized mechanism in serious disease.^[8][9] Comprehensive reviews of reproductive health show that altered levels of sex steroids, gonadotropins, thyroid hormones, and prolactin are clearly linked with menstrual disturbances, infertility, and other gynecologic and andrologic conditions, again supporting the concept that measured deviation from normal hormone ranges is clinically meaningful.^[6][15]

Contradicts

The available high-quality literature does not support “hormone imbalance” as a single, vague diagnosis responsible for nonspecific symptoms without objective endocrine abnormalities; instead, it consistently treats hormone-related disorders as specific, measurable conditions (e.g., hypothyroidism, PCOS, Cushing’s syndrome, hypogonadism) with defined diagnostic criteria.^{[5][6][21][24]} Major guidelines emphasize targeted testing and careful differential diagnosis rather than broad, non-specific attribution of fatigue, weight changes, or mood symptoms to hormone imbalance alone, noting that many such complaints have multifactorial or non-endocrine causes.^{[13][16][21][24]} Reviews of psychiatric and menstrual disorders show that while hormones influence mood and cycles, clear-cut “hormone-specific” psychiatric diagnoses are rare and the relationship is complex, cautioning against simplistic claims that most mental health or menstrual problems are due to generic hormone imbalance.^[3][6][10] The index trials provided (interferon gamma pneumonia prevention, toddler taste study, post-denosumab osteoporosis management, and a Harry Potter mental wellness intervention) do not address hormone imbalance mechanisms or treatment and therefore do not substantiate broad influencer-type claims about hormone imbalance.

Mainstream view

Mainstream medicine accepts hormone imbalance as a valid concept only when tied to specific, objectively demonstrable endocrine disorders (such as thyroid disease, diabetes, PCOS, adrenal insufficiency, hypogonadism) with established diagnostic criteria, laboratory thresholds, and evidence-based treatments. Clinicians and guidelines view the endocrine system as a network of more than 50 hormones whose excess or deficiency can significantly impact metabolism, growth, reproduction, mood, and other systems, but they stress that diagnosis requires targeted history, examination, and appropriate laboratory and imaging tests rather than reliance on symptoms alone.^{[13][14][17][21][24]} The mainstream position is that many serious chronic conditions (diabetes, thyroid disease, reproductive disorders, some cancers, osteoporosis) involve well-characterized hormonal imbalances and should be managed using guideline-directed therapies, while broad non-specific claims that “hormone imbalance” is the root cause of most common symptoms or can be reliably diagnosed or treated through non-standard or unvalidated methods are not supported by high-quality evidence.^{[5][6][13][16][21][24]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“hormone imbalance”

Rule: Virginia practice-of-chiropractic scope; Va. Code § 54.1-2900 / Board definition